You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

who have received no prior treatment

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer Trial in Besançon (Letrozole, Anastrozole, Vinorelbine)

Terminated
  • Breast Cancer
  • Besançon, France
    CHU Besançon
Jan 29, 2021

Breast Cancer Trial in Wuhan (Camrelizumab, Liposomal Doxorubicin, Losartan)

Not yet recruiting
  • Breast Cancer
  • Wuhan, Hubei, China
    Union Hospital, Tongji Medical College of HUST
Oct 27, 2021

HER2-positive Advanced Gastric Cancer, HER2-positive Gastroesophageal Junction Adenocarcinoma Trial (Trastuzumab deruxtecan)

Not yet recruiting
  • HER2-positive Advanced Gastric Cancer
  • HER2-positive Gastroesophageal Junction Adenocarcinoma
  • Trastuzumab deruxtecan
  • (no location specified)
Aug 11, 2023

Treatment Patterns of HR+/HER2- Advanced or Metastatic Breast

Completed
  • HR+/HER2- Advanced or Metastatic Breast Cancer
    • Dublin, Ireland
      Novartis Pharmaceuticals
    May 2, 2023

    Neuroendocrine Tumors, NET, Pancreatic Neuroendocrine Tumor Trial in Newport Beach, Denver, Dallas (nab-sirolimus)

    Not yet recruiting
    • Neuroendocrine Tumors
    • +4 more
    • Newport Beach, California
    • +2 more
    Aug 16, 2023

    Severe Hemophilia A Subjects Who Received BMN 270 inPrior

    Enrolling by invitation
    • Hemophilia A
      • London, United Kingdom
        Royal London Hospital, Barts and the London Hemophilia Center
      Mar 13, 2023

      Glioma Trial (Retreatment Rhenium Liposome)

      Not yet recruiting
      • Glioma
      • Retreatment Rhenium Liposome
      • (no location specified)
      Jul 12, 2022

      Colorectal Cancer Metastatic Trial (HLX26, HLX10)

      Not yet recruiting
      • Colorectal Cancer Metastatic
      • (no location specified)
      Oct 14, 2022

      Multiple Myeloma Trial (Elranatamab, Elotuzumab, Pomalidomide)

      Not yet recruiting
      • Multiple Myeloma
      • (no location specified)
      Nov 28, 2023

      Tucatinib in Locally Advanced or Metastatic HER2-positive Breast

      Recruiting
      • HER2-positive Breast Cancer
      • Essen, Northrhine-Westphalia, Germany
        Universitätsklinikum Essen, Innere Klinik (Tumorforschung)
      May 30, 2022

      Malignant Non-small Cell Tumor of Lung Stage IV Trial in Boston (Capmatinib (INC280))

      Completed
      Has Results
      • Malignant Non-small Cell Neoplasm of Lung Stage IV
      • Capmatinib (INC280)
      • Boston, Massachusetts
        Massachusetts General Hospital
      Mar 11, 2022

      Characterize Access to Specialty Care Received by American

      Recruiting
      • Specialist Referral: Neurology
      • +2 more
      • No Intervention
      • Walnut, California
      • +1 more
      Jan 30, 2023

      COVID-19 Trial in Natal, São Paulo (SCB-2019/Clover, AstraZeneca/Fiocruz, Pfizer/Wyeth)

      Active, not recruiting
      • COVID-19
      • SCB-2019/Clover
      • +2 more
      • Natal, Rio Grande Do Norte, Brazil
      • +1 more
      Apr 10, 2023

      Ovarian Cancer, Ovarian Carcinoma, Platinum-resistant Ovarian Cancer Trial (Pamiparib, Surufatinib)

      Not yet recruiting
      • Ovarian Cancer
      • +4 more
      • (no location specified)
      Aug 8, 2022

      Breast Cancer Trial in Worldwide (Ribociclib, Letrozole or Anastrozole, Goserelin)

      Active, not recruiting
      • Breast Cancer
      • Mobile, Alabama
      • +90 more
      Dec 19, 2022

      Kyprolis® in Combination With Revlimid® and Dexamethasone or

      Recruiting
      • Multiple Myeloma in Relapse
      • Frankfurt, Germany
        Centrum für Hämatologie und Onkologie Bethanien
      Jun 2, 2022

      Endometrial Cancer Trial (MK-2870, Doxorubicin, Paclitaxel)

      Not yet recruiting
      • Endometrial Cancer
      • MK-2870
      • +2 more
      • (no location specified)
      Nov 10, 2023

      Participants Who ReceivedCanGaroo® Envelope, TYRX™ Envelope, or

      Recruiting
      • Cardiac Disease
      • CIED envelope
      • Chandler, Arizona
      • +10 more
      Jun 6, 2022

      Long-Term Follow-Up of TX200-TR101 (STEADFAST Long Term)

      Enrolling by invitation
      • Kidney Transplant Rejection
      • End Stage Renal Disease
      • Urine sample
      • +2 more
      • Leuven, Belgium
      • +5 more
      Aug 3, 2023

      Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma Trial in China (Trastuzumab Deruxtecan)

      Recruiting
      • Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
      • Trastuzumab Deruxtecan
      • Beijing, China
      • +25 more
      Jul 27, 2022

      Breast Cancer Trial in Orange City (ARV-471 (PF-07850327), Palbociclib, Letrozole)

      Recruiting
      • Breast Cancer
      • ARV-471 (PF-07850327)
      • +2 more
      • Orange City, Florida
        Mid Florida Hematology and Oncology Center
      Jun 8, 2023

      Multiple Myeloma, Renal Impairment, Tumors, Plasma Cell Trial in Greece (Isatuximab, Pomalidomide, Dexamethasone)

      Not yet recruiting
      • Multiple Myeloma
      • +7 more
      • Athens, Greece
      • +5 more
      Mar 17, 2022

      Metastatic Renal Cell Carcinoma Trial in Cleveland (Nivolumab, Ipilimumab)

      Active, not recruiting
      • Metastatic Renal Cell Carcinoma
      • Cleveland, Ohio
        Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
      Jan 25, 2023

      Squamous Cell Carcinoma Trial in New York (Standard surveillance, Telemedicine surveillance (tele-surveillance), Questionnaires)

      Recruiting
      • Squamous Cell Carcinoma
      • Standard surveillance
      • +2 more
      • New York, New York
        Memorial Sloan Kettering Cancer Center (All Protocol Activities)
      Aug 17, 2022

      Real-life Current Standards of Care in Relapsed and/or

      Completed
      • Multiple Myeloma
      • No intervention
      • Tucson, Arizona
      • +85 more
      Dec 20, 2022